Avadel Pharmaceuticals PLC (AVDL)
11.88
+0.22
(+1.89%)
USD |
NASDAQ |
Nov 22, 13:38
Avadel Pharmaceuticals Profit Margin (Quarterly): -5.25% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -5.25% |
| June 30, 2024 | -33.30% |
| March 31, 2024 | -100.6% |
| December 31, 2023 | -148.0% |
| September 30, 2023 | -517.2% |
| June 30, 2023 | -4.31K% |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | -7.07% |
| December 31, 2019 | -24.91% |
| September 30, 2019 | -62.30% |
| June 30, 2019 | -49.02% |
| March 31, 2019 | -79.20% |
| December 31, 2018 | -305.3% |
| September 30, 2018 | -79.55% |
| Date | Value |
|---|---|
| June 30, 2018 | -11.76% |
| March 31, 2018 | -36.75% |
| December 31, 2017 | -23.73% |
| September 30, 2017 | 54.64% |
| June 30, 2017 | 62.46% |
| March 31, 2017 | 49.35% |
| December 31, 2016 | 10.99% |
| September 30, 2016 | -62.31% |
| June 30, 2016 | -51.36% |
| March 31, 2016 | -16.73% |
| December 31, 2015 | |
| September 30, 2015 | -59.34% |
| June 30, 2015 | -34.69% |
| March 31, 2015 | 35.59% |
| December 31, 2014 | |
| September 30, 2014 | -142.9% |
| June 30, 2014 | -488.0% |
| March 31, 2014 | -581.9% |
| December 31, 2013 | -42.42% |
| September 30, 2013 | -114.1% |
| June 30, 2013 | -592.9% |
| March 31, 2013 | -171.8% |
| December 31, 2012 | -80.86% |
| September 30, 2012 | -119.0% |
| June 30, 2012 | -98.08% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.31K%
Minimum
Jun 2023
-5.25%
Maximum
Sep 2024
-642.9%
Average
-66.95%
Median
Profit Margin (Quarterly) Benchmarks
| Jazz Pharmaceuticals PLC | 20.38% |
| Medtronic PLC | 15.11% |
| Alkermes PLC | 24.43% |
| Perrigo Co PLC | -1.93% |
| Iterum Therapeutics PLC | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -86.15% |
| Return on Assets | -42.62% |
| Return on Invested Capital | -82.02% |
| Gross Profit Margin (Quarterly) | 87.70% |
| Operating Margin (Quarterly) | -0.65% |
| Return on Net Operating Assets | -101.7% |